About This Course
This course is designed for respiratory care professionals seeking advanced knowledge in the management of COPD and Alpha-1 Antitrypsin (AAT) Deficiency. Participants will gain a comprehensive understanding of AAT deficiency, including identification, genetic testing, and allele interpretation to determine eligibility for augmentation therapy.
The course will cover the principles and administration of augmentation therapy, the critical role of Registered Respiratory Therapists (RRTs) in patient care, and strategies for promoting awareness, education, and smoking cessation in clinical, community, and home settings. By completing this program, learners will be equipped to apply their expertise to improve patient outcomes and advance professional practice.
This educational activity has been supported through grants from Beam Therapeutics and Grifols.
**Please note that all programs require participants to view the entire program before taking the final quiz and obtaining a course certificate.**
What is Alpha-1 Antitrypsin Deficiency?
How is Alpha-1 Antitrypsin Deficiency identified and testing performed?
Understanding of the different alleles, be able to understand which alleles are normal and abnormal along with which alleles qualify for augmentation therapy.
What is augmentation therapy and how is it performed?
Discussing the role of the Registered Respiratory Therapist, Alpha-1 Antitrypsin Deficiency and smoking cessation.
How does the Registered Respiratory Therapist use their skill set to promote awareness and education in healthcare settings, public settings and home settings?
Chapters
Role of a Registered Respiratory Therapist with Alpha-1 Antitrypsin Testing
ThiSpeaker Information
- Heather Hicks, RRT, CTTS
Approved CRCE Hours
1.00
Category
Advertisement